tiprankstipranks
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market
RVPH
Reviva Pharmaceuticals Holdings
RESEARCH TOOLSreports

Reviva Pharmaceuticals Holdings (RVPH) Financial Statements

Compare
1,204 Followers

Reviva Pharmaceuticals Holdings Financial Overview

Reviva Pharmaceuticals Holdings's market cap is currently $9.44M. The company's EPS TTM is $; its P/E ratio is -1.67; Reviva Pharmaceuticals Holdings is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -724.74K
Operating Income$ -30.80M$ -39.50M$ -24.31M$ -10.10M$ -2.43M
EBITDA$ -29.88M$ -39.21M$ -24.11M$ -10.10M$ -2.33M
Net Income$ -29.92M$ -39.26M$ -24.34M$ -8.52M$ -3.78M
Balance Sheet
Cash & Short-Term Investments$ 13.48M$ 23.37M$ 18.52M$ 29.69M$ 8.76M
Total Assets$ 15.50M$ 23.70M$ 18.92M$ 31.40M$ 8.76M
Total Debt$ 458.15K$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -13.02M$ -23.37M$ -18.52M$ -29.69M$ -8.76M
Total Liabilities$ 14.69M$ 17.98M$ 10.53M$ 2.72M$ 3.30M
Stockholders' Equity$ 812.57K$ 5.72M$ 8.39M$ 28.69M$ 5.47M
Cash Flow
Free Cash Flow$ -33.54M$ -28.32M$ -18.96M$ -10.67M$ -4.07M
Operating Cash Flow$ -33.54M$ -28.32M$ -18.96M$ -10.67M$ -4.07M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 23.65M$ 33.17M$ 7.79M$ 31.60M$ 12.83M
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

Income Statement >

Reviva Pharmaceuticals Holdings Debt to Assets

Balance Sheet >

Reviva Pharmaceuticals Holdings Cash Flow

Cash Flow >

Reviva Pharmaceuticals Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >